Evaluation of Enteral Nutrition Biscuits for Inducing Remission in Moderate-to-severe Crohn's Disease
NCT06362863 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52
Last updated 2024-04-12
Summary
By conducting a randomized controlled study of the role of enteral nutrition biscuits in the induction of remission in moderate-to-severe Crohn's disease, we will evaluate to investigate the role of enteral nutrition biscuits in the induction and remission phases of moderate-to-severe Crohn's disease; to assess patient adherence to enteral nutrition biscuits and the timing of their application; to assess the role of enteral nutrition biscuits in biologically refractory patients; and to assess the role of enteral nutrition biscuits in the remission of perianal, small bowel, and colonic lesions.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
enteral nutrition biscuits
Addition of enteral nutritional biscuits to existing pharmacological treatment.
Sponsors & Collaborators
-
Ping An
lead OTHER
Principal Investigators
-
Ping An · Renmin Hospital of Wuhan University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-30
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
More Related Trials
-
Efficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction Remission
NCT01820247 ·Status: UNKNOWN ·Phase: NA
-
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
NCT01466374 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease
NCT00295165 ·Status: TERMINATED ·Phase: PHASE3
-
Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)
NCT01218360 ·Status: COMPLETED
-
Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668)
NCT00329420 ·Status: COMPLETED ·Phase: PHASE2
-
Prebiotics and Diet to Reduce "Leaky" Gut in First Degree Relatives of Crohn's Disease Patients
NCT03950336 ·Status: COMPLETED ·Phase: NA
-
Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease
NCT00102921 ·Status: COMPLETED ·Phase: PHASE2
-
Active Surgical Intervention on Crohn's Disease
NCT05523050 ·Status: UNKNOWN ·Phase: NA
-
Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery
NCT00688636 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
NCT01393626 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease
NCT00206674 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease
NCT00306215 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After Surgery
NCT04160325 ·Status: RECRUITING ·Phase: NA
-
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
NCT01277666 ·Status: COMPLETED ·Phase: PHASE3
-
PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial
NCT06301477 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
NCT01369329 ·Status: COMPLETED ·Phase: PHASE3
-
Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease
NCT00329550 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD)
NCT01823042 ·Status: UNKNOWN ·Phase: NA
-
Study of Sargramostim in Moderately to Severely Active Crohn's Disease
NCT00329537 ·Status: TERMINATED ·Phase: PHASE2
-
Fecal Transplant for Crohn's Disease
NCT03078803 ·Status: COMPLETED ·Phase: PHASE2
-
A Crohn's Disease Diet to Reduce Symptoms of Crohn's Disease
NCT01897090 ·Status: WITHDRAWN ·Phase: NA
-
Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery
NCT05214430 ·Status: COMPLETED ·Phase: NA
-
Cranberry and Gut Health in Crohn's Disease
NCT07170462 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT04397263 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease
NCT03266484 ·Status: COMPLETED ·Phase: NA